Author

Anat Abramov

Weizmann Institute of Science

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron JavittiD· 1 shared Angham Ibraheem· 1 shared Arseniy A. LoboviD· 1 shared Benjamin F. CravattiD· 1 shared Brenda Arlene SchulmaniD· 1 shared Bruno N. MelilloiD· 1 shared Daisuke OgasawaraiD· 1 shared Daoud Sheban· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron JavittORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1

Merav D. Shmueli, Yongfeng Tao, Ekampreet Singh, Matthias P. Kramer, Anat Abramov, Tuval Aizik, Daoud Sheban, Arseniy A. Lobov, Karin Goldberg, Angham Ibraheem, Ronen Shteinvil, Aaron Javitt, Yishai Levin, Michael A. Schafroth, Daisuke Ogasawara, , Yifat Merbl

This study identifies a small molecule targeting PSME4, which stabilizes STAT1 and reprograms tumor inflammation, suppressing tumor growth by altering cytokine signaling.

bioRxiv · Oct 16, 2026 · PreprintCancer Biology